Agilon Health Reports Q1 2026 Financial Results with Revenue Decline and Increased Net Income

Agilon Health, Inc. reported its financial results for the first quarter of 2026, revealing total revenues of $1.42 billion, a decrease of 7% from $1.53 billion in the same period of 2025. The decline in revenue was primarily attributed to a 13% drop in Medicare Advantage (MA) membership, reflecting the company's strategic decision to exit certain markets and focus on profitability. Despite the revenue decrease, the company achieved a net income of $48.92 million, a significant increase from $12.11 million in the prior year, driven by improved medical margins and reduced operating expenses.

The company's medical services revenue, which constitutes the bulk of its total revenue, fell to $1.42 billion from $1.53 billion year-over-year. Medical services expenses also decreased by 9% to $1.27 billion, reflecting the impact of the reduced membership and a disciplined approach to contracting. The gross profit for the quarter was reported at $65 million, up from $51 million in the previous year, indicating a 28% increase. The medical margin improved to $149 million, compared to $128 million in the same quarter of 2025, highlighting the company's efforts to enhance operational efficiency.

Agilon Health's operational metrics showed a total of 426,300 MA members as of March 31, 2026, down from 490,700 a year earlier. The company also reported a decrease in platform support costs, which fell to $37.6 million from $44.2 million, reflecting ongoing cost management initiatives. The company’s employee headcount remained stable, with 16.6 million shares of common stock outstanding following a 1-for-25 reverse stock split executed on March 30, 2026.

In terms of strategic developments, Agilon Health appointed Tim O’Rourke as the new Chief Executive Officer and President, effective May 7, 2026. The company continues to focus on its partnerships with physician groups to create a Medicare-centric, globally capitated business model. As of the end of the first quarter, Agilon Health had cash and cash equivalents totaling $140 million, along with restricted cash of $71.6 million, positioning the company to meet its operational needs.

Looking ahead, Agilon Health anticipates that its existing cash reserves, along with available borrowing capacity under its credit facility, will be sufficient to support its working capital and capital expenditure needs over the next 12 months. However, the company acknowledges the potential need for additional capital resources to fund future growth initiatives. The management remains optimistic about the long-term prospects of its business model, which aims to empower primary care physicians and improve healthcare delivery for seniors across the United States.